Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program-Reference-Cited by-同舟云学术

Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

Published:2010-08-25 Issue:7 Volume:55 Page:1329-1337
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Carol Hernan,Morton Christopher L.,Gorlick Richard,Kolb E. Anders,Keir Stephen T.,Reynolds C. Patrick,Kang Min H.,Maris John M.,Billups Catherine,Smith Malcolm A.,Houghton Peter J.,Lock Richard B.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference37 articles.

1. Ten years of protein kinase B signalling: A hard Akt to follow;Brazil;Trends Biochem Sci,2001

2. AKT/PKB signaling: Navigating downstream;Manning;Cell,2007

3. PI3K-Akt pathway: Its functions and alterations in human cancer;Osaki;Apoptosis,2004

4. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability;Silva;J Clin Invest,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials;Antibiotics;2023-09-07

2. Evaluation of the pan‐class I phosphoinositide 3‐kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma;Pediatric Blood & Cancer;2022-10-17

3. Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials;Pharmacological Research;2022-09

4. Akt inhibitors in cancer therapy;Protein Kinase Inhibitors;2022

5. Morusin Inhibits Human Osteosarcoma via the PI3K-AKT Signaling Pathway;Current Pharmaceutical Biotechnology;2020-11-28